Described herein are pharmaceutical packaging units which avert oxidative degradation of morphine, hydromorphone, promethazine together with other oxygen-sensitive drugs, this kind of systems which include a syringe using an oxygen permeable idea cap, a hermetically sealed oxygen barrier blister pac